RNA interference tolerates 2'-fluoro modifications at the Argonaute2 cleavage site

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Development

Background:

• Short interfering RNA (siRNA) is crucial for RNA interference (RNAi) based drug development.
• RNA-induced silencing complex (RISC) activation requires sense strand degradation, but modifications at the Argonaute2 (Ago2) cleavage site are underexplored.

Purpose of the Study:

• To investigate the impact of novel 2 acronym{'-F}-purine modifications on siRNA efficacy and toxicity.
• To explore modifications at the Ago2 cleavage site within the siRNA sense strand.

Main Methods:

• Chemically modified siRNAs with various 2 acronym{'-F} substitutions at the Ago2 cleavage site were synthesized.
• Biological efficacy was tested in cells expressing human tartrate-resistant acid phosphatase (TRACP).
• Target mRNA and protein knockdown, along with siRNA toxicity, were monitored.

Main Results:

• All 2 acronym{'-F}-modified siRNAs achieved target knockdown at nanomolar concentrations.
• Modified siRNAs exhibited high thermal stability.
• The study provides the first evidence that 2 acronym{'-F} modifications at the sense-strand cleavage site are tolerated during RISC activation.

Conclusions:

• 2 acronym{'-F} modifications at the Ago2 cleavage site enhance the biological efficacy of siRNAs in vitro.
• These modifications offer a promising strategy for developing more effective RNAi-based therapeutics.
• The findings advance the understanding of siRNA structure-activity relationships in RNAi.